Peer-reviewed articles, experimental protocols, and in-depth analysis of genetic mechanisms
Discover how imetelstat, a novel telomerase inhibitor, shows remarkable promise for treating advanced myelofibrosis in patients who have failed JAK inhibitor therapy.